- Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assetsLupin has spun out two clinical-phase cancer drug candidates to create Kaveri Therapeutics, a U.S.-based startup that plans to raise cash for further development. Kaveri’s programs hit targets purs…Fierce Biotech · 3d ago↗ source
- Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial roleDan Malarek is leaving his role as chief executive of Roche’s sequencing subsidiary Foundation Medicine as he takes up the mantle as President and CEO of Roche Diagnostics North America.Fierce Biotech · 3d ago↗ source
- Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trials<p>Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.</p>